explore -WSS

explore

author：knowledge 2025-09-27 23:12:05 - browse：73

Are venture capitalists OK? Are bolt-ons good for business? And when is it safe to say someone overpaid?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how biotech’s downturn has made life difficult not just for startups but also the VCs they rely on for much-needed funding. We also take a look at Gilead Sciences’ struggle to turn itself into an oncology company and the latest biotech to get bought out by a major pharma firm.

For more on what we cover, here’s more on Gilead; here’s the news on Inhibrx; here’s the latest on biotech venture capital; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Leading voice in opioid treatment defends methadone clinic system

focus

WSS

Leading voice in opioid treatment defends methadone clinic system

SCOTUS questions limit to govt efforts to fight misinformation

Methadone treatment changes are coming. Do they go far enough?

Health AI adoption puts security, privacy startups on investors' radar

Gene editing the human germline: What are the risks?

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

focus

explore

leisure time

New air purifier tech could be key to improving indoor air quality

Medicare says breakthrough device reimbursement rule to come by summer

Drug repurposing or repositioning? The language matters

Creating egg and sperm cells from stem cells raises ethical issues

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Orchard's therapy for neuron disease in children wins FDA approval

Duchenne breakthrough therapy leaves behind pioneering families

Colonoscopy prep: Liquid

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Asbestos, a deadly carcinogen, banned by EPA

explore

Baby aspirin cuts fat buildup in liver disease patients, in small study

Readout LOUD podcast: What to know about H5N1 bird flu

Bird flu outbreak in cows is latest avian flu curveball

Dairy farmers resist CDC push for PPE against bird flu virus

Steward Health Care files for bankruptcy

Orchard's therapy for neuron disease in children wins FDA approval

focus

hotspot

focus

leisure time